Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1
Nephrol Dial Transplant
.
2023 Jun 30;38(7):1773-1775.
doi: 10.1093/ndt/gfad049.
Authors
Elisabeth L Metry
1
,
Sander F Garrelfs
1
,
Hessel Peters-Sengers
2
3
,
Frederic M Vaz
4
,
Joost A Bijlsma
5
6
,
Aegida Neradova
5
6
,
Michiel J S Oosterveld
1
,
Jaap W Groothoff
1
Affiliations
1
Department of Pediatric Nephrology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
2
Center for Experimental and Molecular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
3
Department of Epidemiology and Data Science, VU University Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
4
Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
5
Department of Nephrology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
6
Dianet Dialysis Centre, Amsterdam, The Netherlands.
PMID:
36898675
PMCID:
PMC10310499
DOI:
10.1093/ndt/gfad049
No abstract available
MeSH terms
Glycolates
Humans
Hyperoxaluria*
Hyperoxaluria, Primary*
Oxalates
Renal Dialysis
Substances
Oxalates
glycolic acid
Glycolates
Supplementary concepts
Primary hyperoxaluria type 1